Dr. Aparicio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yawkey 9a
Boston, MA 02114Phone+1 617-726-6500
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2008 - 2011
Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2004
Certifications & Licensure
MA State Medical License 2007 - 2026
ME State Medical License 2022 - 2025
NH State Medical License 2023 - 2025
PA State Medical License 2008 - 2012
NY State Medical License 2007 - 2009
American Board of Internal Medicine Hospice and Palliative Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).Laura M Spring, Lauren Scarpetti, Arielle J Medford, Andrzej Niemierko, Amy Comander
NPJ Breast Cancer. 2025-01-07 - Framework for Considering Primary and Subspecialty Palliative Care and Guiding Serious Illness Communication for Patients With Breast Cancer.Lindsay A Dow, Jennifer Kapo, Frances Boyle, Jennifer A Shin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - 2 citationsAdjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.Shannon McLaughlin, Erika Nakajima, Yael Bar, Jennifer A Hutchinson, Jennifer Shin
Therapeutic Advances in Medical Oncology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
